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Abstract
Enshrined in this review are the biogenic fabrication and applications of coated and uncoated iron and iron oxide
nanoparticles. Depending on their magnetic properties, they have been used in the treatment of cancer, drug
delivery system, MRI, and catalysis and removal of pesticides from potable water. The polymer-coated iron and iron
oxide nanoparticles are made biocompatible, and their slow release makes them more effective and lasting. Their
cytotoxicity against microbes under aerobic/anaerobic conditions has also been discussed. The magnetic moment
of superparamagnetic iron oxide nanoparticles changes with their interaction with biomolecules as a consequence
of which their size decreases. Their biological efficacy has been found to be dependent on the shape, size, and
concentration of these nanoparticles.
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Introduction
Many physical and chemical methods have been devel-
oped for the fabrication of nanoparticles. However, the
chemicals used in these procedures leave toxic residues
and pollute the environment. Therefore, biogenic syn-
thesis of nanoparticles using fungi, bacteria, actinomy-
cetes, algae, and higher plants have emerged as potential
nanofactories which are cost effective and environment
friendly [1–8]. The metal and metal oxide nanoparticles
are widely used in agriculture, drug delivery, cosmetics,
photonic crystals, analysis, food, coatings, paints, cataly-
sis, and material science [1, 9–12].
At present, the application of iron oxide nanoparticles
in medical and other sectors appears to be increasing
fast [1, 13–17]. Antibacterial activity of Argemone mexi-
cana treated with iron oxide nanoparticles against Pro-
teus mirabilis and Escherichia coli has been reported
[18]. Iron nanoparticles fabricated using five different
plants (Lawsonia inermis, Gardenia jasminoides, Azadir-
achta indica, Camellia sinensis leaf extract, and Cinna-
mon zeylanicum bark extract) were found to be toxic to
many bacterial strains [19].
Table 1 summarizes the physical parameters of iron
and iron oxide nanoparticles. Biogenic fabrication of the
iron and iron oxide nanoparticles using extracts of dif-
ferent parts of a variety of plants such as Euphorbia
milli, Tridax procumbense, Tinospora cordifolia, Datura
innoxia, Calotropis procera, and Cymbopogon citratus
have also been reported [44]. Magnetic iron oxide nano-
particles have great potential as a drug carrier and MRI
agent and in tissue repair and in the treatment of tumor
[45]. They are also used as pigments in paints and cer-
amics and as catalysts for the manufacture of ammonia
by Haber’s process and oxidation of alcohols to alde-
hydes [46–48] and other chemicals. The toxicity of iron
oxide nanoparticles can be employed in inhibiting the
growth of bacteria, fungi, and other pathogens [49].
Fe2(SO4)3, FeSO4·H2O, and FeSO4·7H2O are used as
herbicides, micronutrient for crops, an electrolyte in dry
batteries, a supplement in animal feed, and as a
galvanizer. These salts are also used in the purification
of water, sewage treatment, and in textiles [50]. Iron
nanoparticles, in the absence of air, act as better anti-
microbial agent than in the presence of oxygen. It is be-
cause rusting of iron occurs in the presence of oxygen
and water.
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Although conflicting reports with reference to toxicity
of iron oxide nanoparticles have been received, even
then, they are useful in trace amounts [51–56]. However,
the experimental evidences gathered thus far indicate
that superparamagnetic iron oxide nanoparticles coated
with R–COOH or R–NH2 are less toxic than bare nano-
particles [57, 58]. For maximum performance, nanopar-
ticles must be of uniform size and there should not be
much variation in temperature because the magnetic
moment varies with temperature due to the alignment
of spins of free electrons [59].
The application of magnetic nanoparticles is not re-
stricted to only material science but has expanded its
tentacles in almost all areas of science such as agricul-
ture, biomedical, and engineering [60–62]. The shape
and size of these nanoparticles can be controlled if pH,
temperature, and concentration of all components, in
the presence of a surfactant, are monitored [63–66].
Their properties vary with their dimensions [67, 68].
The nanoparticles should be of different sizes for differ-
ent uses. For instance, in case of biomedical application,
the iron and iron oxide nanoparticles should exhibit
superparamagnetic behavior at ambient temperature
[69–71] but for their use as therapeutic agent and in
diagnosis, they should be uniformly smooth and stable
at physiological pH [72]. Fe2O3 and Fe3O4 are com-
monly employed for biomedical application. The degree
of structural variation depends on the process of synthe-
sis of the nanoparticles. The superparamagnetism of
nanoparticles exists even in the absence of external
magnetic field. Iron and iron oxide nanoparticles are
used in the removal of organic substances in aqueous
medium [73–75].
Although iron and iron oxide nanoparticles are exten-
sively used in MRI, immunoassay, drug delivery system,
catalysis, and magnetic material in biology and medicine,
their application in today’s life is more significant [76].
The surfaces of nanoparticles used in drug delivery are
generally functionalized with drugs, protein, and genetic
materials [77, 78]. Since these nanoparticles have in-
creased surface area, they reduce the quantity of the
drug to minimum and also reduce the adverse effect of
the drug on normal cells [79–82].
Besides their technological applications, iron and mag-
netic iron oxide nanoparticles are of great fundamental
scientific interest. In recent years, emphasis has been
given to target drug delivery by superparamagnetic iron
oxide nanoparticles [83, 84] and in vivo application such
as detoxification and hyperthermia. In order to reduce
the toxicity of these nanoparticles, they are generally
coated with nontoxic and biocompatible materials.
These nanoparticles can bind with drugs, enzymes, and
antibodies and subsequently directed to a specific organ
or tissue through an external magnetic field [85].
Magnetization of nanoparticle is therefore essential. It is
of prime importance that the nanoparticles should be se-
lected from among the transition metal ions which are
highly magnetic in nature. Nonfunctionalized iron oxide
nanoparticles have been used for labeling leucocytes,
lymphocytes, etc. [86–88]. Cellular uptake of iron oxide
nanoparticles can be increased by coating them with
dendrimers [89]. Magnetic nanoparticle conjugate is
Table 1 Size and morphology of iron and iron oxide
nanoparticles fabricated from plant system
Reference Plant Morphology Size (nm)
[20] Green tea Spherical 70–80
[21] Green tea Spherical 5–15
[22] Tea powder Differs according
to the quantity of
tea extract
–
[23] Green tea Irregular clusters 40–60
[24] Green tea, oolong
tea, and black tea
Irregular spherical 20–40
[25] Oolong tea Spherical 40–50
[26] Sorghum bran Spherical 40–50
[27] Eucalyptus Spherical 50–80
[28] Eucalyptus Cubic 40–60
[29] Eucalyptus Spherical 20–80
[30] Pomegranate – 100–200
[31] Plantain peel Spherical Less than 50
[32] Banana peel – 10–25
[33] Tangerine peel Spherical 50
[34] Dodonaea viscosa Spherical 50–60












[39] Terminalia chebula Chain-like Less than 80
[40] Eucalyptus tereticornis Spherical 40–60
[40] Melaleuca nesophila Spherical 40–60
[40] Rosmarinus officinalis Aggregates like
grapes
–
[19] Lawsonia inermis Distorted hexagonal-
like appearance
21
[19] Gardenia jasminoides Shattered rock-like 32
[41] Amaranthus dubius Spherical 43 to 220
[42] Kappaphycus alvarezii Spherical 14.7
[43] Padina pavonica – 10–19.5
[43] Sargassum acinarium – 21.6–27.4
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made of iron oxide nanoparticles, covalently bind with
methotrexate, and can act both as a contrast agent in
MRI and drug carrier.
An attempt has been made to review the biogenic fab-
rication of magnetic iron and iron oxide nanoparticles
and their application in drug delivery and cancer therapy
and as a sensor for the detection of pesticides.
Biogenic Fabrication of Magnetic Nanoparticles
Fabrication of iron oxide nanoparticles at room
temperature, using tea (C. sinensis) polyphenols has been
reported [21]. These nanoparticles showed highest rate
of bromothymol blue degradation in comparison to
Fe-ethylenediaminetetraacetic acid (Fe-EDTA) and
Fe-ethylenediamine-disuccinic acid (Fe-EDDS). In an-
other study, Muthukumar and Matheswaran [90] ob-
tained iron oxide nanoparticles using Amaranthus
spinosus leaf aqueous extracts. These nanoparticles were
spherical with rhombohedral phase structure, smaller in
size with large surface, and less aggregation than those
produced with sodium borohydride. In this, the photo-
catalytic and antioxidant activities of the leaf extract as
well as the sodium borohydride-mediated iron oxide
nanoparticles were also studied. A. spinosus leaf extract-
mediated iron oxide nanoparticles exhibited better
photocatalytic and antioxidant activities than those pro-
duced by sodium borohydride. Iron nanoparticles
synthesized using green tea extracts have been shown to
act as Fenton-like catalysts for the degradation of cat-
ionic dyes such as methylene blue and anionic dyes like
methyl orange [23]. It has been found that iron nanopar-
ticles synthesized from green tea extract removed almost
100 % of methylene blue and methyl orange at an initial
dye concentration of 10 and 100 mg L−1. However, when
iron nanoparticles were synthesized using the conven-
tional borohydride reduction method, the efficiency was
somewhat less for methylene blue (96.3 % for 10 mg L−1
and 86.6 % for 100 mg L−1) and significantly less in the
case of methyl orange (61.6 % for 10 mg L−1 and 47.1 %
for 100 mg L−1). Fe3O4 nanoparticles were synthesized
by hydrothermal method using aloe vera plant extract
[91]. Authors have reported that with increase in the
reaction temperature and time resulted in magnetite
nanoparticles with increased crystallinity and saturated
magnetization. Herrera-Becerra et al. [92] have synthe-
sized iron oxide nanoparticles by exposing pretreated
and milled powder of Medicago sativa to the salt solu-
tion of ferrous ammonium sulfate. For this fabrication,
48 h was given. At pH 10, smaller particles with greater
proportion of Fe2O3 were produced whereas larger
nanoparticles were produced at lower pH (pH 5).
Lunge et al. [93] have synthesized magnetic iron oxide
nanoparticles of 2–25 nm with cuboid/pyramid structure
using tea waste template. They exhibited high adsorption
capacity for arsenic. It showed very low cost (Rs. 136 per
kg). These nanoparticles may be reused up to 5 cycles
and regenerated using NaOH. The estimated cost of
As(III) removal from water was estimated to be negli-
gible. Leaf extracts of 26 plants were used for the pro-
duction of nanoscale zero-valent iron particles [37]. The
optimum temperature (80 °C) was noted; however, for
the extraction time and leaf mass, solvent volume ratio
was varied according to the leaf type. Thakur and Karak
[32] used banana peel ash extract to synthesize iron
oxide nanoparticles; and aqueous extract of Colocasia
esculenta leaves was used to reduce graphene oxide. Iron
oxide formation was validated by XRD (peaks at 30.15,
36.2, 43.32, 53.89, and 29) and FTIR (stretching Fe–O)
(Fig. 1a, b). In this study, the nanohybrids exhibited a
good reusability with insignificant decrease in efficiency
even after the third cycle [32].
Au–Fe3O4 composite with magnetic core was primarily
produced by co-precipitation of Fe2+ and Fe3+. Further,
Eucalyptus camaldulensis was used for the reduction of
Au+3 on the surface of magnetite nanoparticles and for
the functionalization of the Au–Fe3O4 nanocomposite
Fig. 1 a XRD patterns of (i) iron oxide nanoparticles and (ii) iron oxide/reduced graphene oxide nanohybrid and b FTIR spectra of (i) reduced
graphene oxide nanohybrid [94] and (ii) iron oxide/reduced graphene oxide nanohybrid [32]
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particles [95]. UV–vis spectra showed a redshift due to
the surface plasmon resonance of Au. The highest absorb-
ance was observed for gold nanoparticles at 530 nm (solid
line curve) whereas Au– composite nanoparticles showed
a peak at 608 nm (dotted line) which agreed with previ-
ous reports (Fig. 2) [96–99]. It has also been observed
by many other researchers [96–98, 100].
Senthil and Ramesh [35] synthesized iron oxide nano-
particles by the reduction of ferric chloride solution
using Tridax procumbens leaf extract containing carbo-
hydrates with an aldehyde group as a reducing agent.
Further, these nanoparticles exhibited antibacterial activ-
ity against Pseudomonas aeruginosa.
Recently, Ehrampoush et al. [33] have reported that
the size of iron oxide nanoparticles synthesized from
tangerine peel is dependent on its concentration. The
size of nanoparticles decreases with increasing concen-
tration of tangerine peel extract from 2 to 6 %. In
addition, they have reported that these nanoparticles can
be a good adsorbent for the removal of cadmium from
wastewater.
Biomedical Application of Magnetic Nanoparticles
Therapeutic Applications
Hyperthermia is a simple technique used to destroy
tumor cells by raising their temperature to 41–45 °C.
Since the living cells can undergo repair, they are
rejuvenated while damage of the tumor cells is an
irreversible process [101–103]. This magnetic hyper-
thermia is more effective when the iron oxide nano-
particles (IONP) are small and uniform. Their surface
is generally made biocompatible by coating them with
organic polymers or bioactive molecules for their slow
release.
Cellular Labeling and Cell Separation
In vivo cell separation can be done by cell labeled with
ferro paramagnetic substances [104] as the labeled cells
can be detected by MRI [105]. They can be labeled by
one of the two techniques: (a) attaching magnetic parti-
cles to the cell surface [106] or (b) internalizing biocom-
patible magnetic particles by fluid phase endocytosis
[107]. The most appropriate technique for cell labeling
is to modify the nanoparticle surface with a suitable
ligand such as transferrin, lactoferrin, albumin, and insu-
lin which are generally biocompatible. Such receptors
have been shown [108] to internalize without disturbing
the nanoparticles. Gupta and Gupta [66] have demon-
strated that supramagnetic nanoparticles derivatized
with proteins like lactoferrin, transferrin, and ceruloplas-
min have strong affinity for receptors on the human
fibroblasts surface, which inhibit the phagocytosis. These
nanoparticles of less than 20 nm size have high
magnetization value. Their influence on dermal fibro-
blast has been assessed in terms of adhesion viability
and morphology by SEM and TEM images.
The interaction of the protein-coated nanoparticle is
size dependent since different particles respond differ-
ently. Although there is a significantly visible difference
in the interaction between fibroblast cell and coated/un-
coated supramagnetic nanoparticle, no attempt has been
made to realize the magnetic moment value of iron
oxide nanoparticles, which changes as a consequence of
its binding with proteins and other biomolecules. Iron in
the trivalent state in Fe2O3 is in high spin state with five
unpaired electrons in its d orbital but the moment it is
coated with proteins, it goes to low spin state with a
consequent change in the repulsion and magnetic
moment value from 5.91 BM to 1.73 BM corresponding
to one unpaired electron. It is due to the complex for-
mation of Fe3+ with protein which being a strong ligand
forces the electrons to be paired up. As a result, the Fe3+
is reduced in size but surface area increases due to com-
plexation with the protein. The magnetic moment and
reduction in size of Fe2O3 nanoparticle seems to be the
key factor in the process of internalization and phagocyt-
osis. It has been suggested that tissue repair can be done
either by welding or soldering when polymer-coated
nanoparticles are placed between two tissue surfaces.
Temperature greater than 50 °C is produced by denatur-
ation of tissue and also by absorption of light by coated
nanoparticle [109].
Tissue Repair
The above method suggested for tissue repair is not
convincing as the same temperature is produced to des-
troy the tumor cell which is supposed to join the two
damaged normal cells [66]. The hypothesis first shows
denaturation and then connecting the cells through
Fig. 2 Absorbance spectra of gold nanoparticles (solid line) and
magnetite-gold composite nanoparticles (dotted line) [95]
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other proteins. It appears as if the denaturation has two-
fold purposes; some proteins are disintegrated from the
cell at 50 °C and some proteins remain unaffected which
subsequently join the cells together. When gold/silica-
coated Fe2O3 nanoparticles are coated on the tissues,
they may prevent further damage but it seems unlikely
that two unit cells are joined together. However, the self-
repairing of the damaged tissue is a natural process that
does not require raising the temperature of the tissues.
Treatment of Cancer
Wu et al. [109] have shown that gold-coated iron nano-
particles suppress cancer cell growth in oral and colorec-
tal cancer cells in vivo and in vitro [110]. Although the
healthy cells are equally exposed to iron nanoparticle,
they are not much affected and the replication of cancer
cells is inhibited. The cytotoxicity is due to the magnetic
properties of the elemental iron nanoparticle; the oxida-
tion of which is delayed by coating them with gold. As
the oxidation of iron nanoparticles begins, the cytotox-
icity decreases towards cancer cells. In fact, the gold
coating slowly dissolves to release the iron nanoparticle.
The reactive oxygen species (ROS) is generated which
triggers the process of cytotoxicity. It has also been
observed that the addition of ROS scavenger does not
protect the cancer cells from the nanoparticles with an
iron core and gold shell (Fe@Au)-induced cytotoxicity.
Decrease in mitochondrial membrane potential in can-
cerous cells occurs when treated with Fe@Au, although
it is not clearly known as to how it interferes with the
normal function of the mitochondria. Since the mito-
chondria are redox sensitive, they are targeted by
Fe@Au. Iron is slowly oxidized, due to which, perhaps
the mitochondrial membrane potential decreases. The
cytotoxicity of Fe@Au towards cancer cells is an irre-
versible process, while the healthy cells are also affected
but they recover within 24 h. The oxidation of iron
nanoparticles and generation of ROS are simultaneous
processes (Fig. 3).
Fe0@Au þ mitochondria→ Fenþ@AuO
þ mitochondria
Fe@Au caused a shock to the mitochondria within
4 h, but the cancer cells could not recover from the
damage caused by them. Further, it caused a sequential
autophagy and inhibited the cancer cell growth.
Drug Delivery
Mahmoudi et al. [58] have studied the application of
supraparamagnetic iron oxide nanoparticle (SPION) in
drug delivery. The drugs are bound on SPION surface or
encapsulated in magnetic liposomes and microspheres.
SPIONs can deliver peptides, DNA, chemotherapeutics,
and radioactive and hyperthermic drugs. They are
designed such that the drug or ligand is bound to its sur-
face and guided with an external magnetic field to the
Fig. 3 Fe@Au induced a cancer cell-specific cytotoxicity through the mitochondria-mediated autophagy [109]
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desired site. The nanoparticles enter the target cells and
deliver the drug there (Fig. 4).
When the drug is dissolved inside the target cell, the
SPIONs are exposed to other cells. This process can
reduce the quantity of drug, absorption time, and inter-
action of drug with nontarget cells. However, it is essen-
tial that iron nanoparticles should be magnetic and
smaller than the target cells so that they can easily
diffuse into them. Since large quantity of SPIONs cause
agglomeration, their high concentration may be avoided.
From in vivo experiments, it has been shown that in
most cases, the drug is immediately delivered due to the
bursting of the nanobubbles carrying the drug, as a con-
sequence of which insufficient quantity of the drug
reaches the target cells.
Mahmoudi et al. [111] synthesized cross-linked poly-
ethylene glycol co-fumarate-coated iron oxide nanoparti-
cles and loaded them with tamoxifen to see if it can
reduce the burst time. Interestingly, it was found to
reduce the burst time by 21 %. In a similar experiment,
Guo et al. [112] loaded monodispersed SPION having a
mesoporous structure, with doxorubicin, and observed
that it had very high drug loading capacity and slow re-
lease. The drug release can be controlled by permeabil-
ity, temperature, sensitivity, pH, surface functionality,
and biodegradability of nanoparticles [113].
Colloidal magnetic nanoparticles are used in drug
delivery at a desired target without interacting with
other living cells. In the case of breast cancer (BT 20
cells), polyethylene glycol (PEG)-coated nanoparticles
ranging between 10 and 100 nm were found to pene-
trate into the cells [114]. It is believed that since PEG
is appreciably soluble in both polar and nonpolar sol-
vents, it releases the magnetic nanoparticles at the
tumor cells. Gupta and Gupta [66] have shown that
the efficacy of magnetic microspheres in the targeted
delivery of the incorporated drug is mainly due to
magnetic effects. However, it is true for magnetic
nanoparticle only, but innocuous and biocompatible
nanoparticles of other metals such as gold and silver
of smaller size [115] are known to be more effective
than the larger particles of the same metal as drug
carrier [116]. This technique is cost effective and re-
duces the quantum of drug to be transported to the
site of use. Also, it protects the normal healthy cells
from adverse effects of the drug.
Since the magnetic iron oxide nanoparticles are an ex-
cellent drug carrier, they are used in chemotherapy.
However, iron oxide nanoparticles do not influence the
human fibroblasts cells (IMR-90). It means that they are
selective towards cancer cells. Khan et al. [117] demon-
strated that when both the cancer cells (A549) and nor-
mal cells are exposed to iron oxide nanoparticles in a
concentration range of 10–100 μg/ml for 24–48 h, ne-
crosis of cancer cells occurs leading to their death. Loss
of mitochondrial membrane potential and depletion of
ATP suggest that necrosis is the major cause of cytotox-
icity of cancer cells rather than apoptosis. ROS gener-
ation has been evidenced in A549 cells which are
concentration and time dependent.
A variety of bimetallic nanoparticles of the type
MFe2O4 (where M = divalent Mg, Fe, Co, Ni, Cu, and
Zn) containing two metal ions has been reported for
biomedical applications. Their magnetic properties are
dependent on the number of unpaired electrons in the d
orbital of transition metal ions. Multifunctional magnetic
nanoparticles (MNPs) can be prepared by coating them
with gold, silica, zinc oxide, polymer, liposome, etc. They
can be further functionalized to make MNPs stable and
multifunctional [118]. Xu and Sun [119] have attempted
to deliver cisplatin to solid tumor through Fe3O4
HMNPs.
They have produced small pores in the polycrystal-
line nanoparticles by heating in oleic acid which al-
lows the drug to be diffused easily in these pores. It
has been shown schematically that the drug is deliv-
ered via ligand exchange. However, it is known that
cisplatin is labile in aqueous medium and can react
with water as shown below followed by exchange with
surfactant.
Fig. 4 Drug delivery through nanoparticles on the target cells
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Magnetic targeting of diseased cells by SPION has
been done in some cases [120]. In order to increase the
target yield, SPIONs are generally coated with polymers
and functionalized by attaching carboxyl groups, biotin,
avidin, carbodiimide, or any other biomolecule [121–123].
When the drug is carried at the target cell (tumor cell), it
has to be released either by external force or by changes
in pH, osmotic pressure, or temperature [124]. The drug
is then picked up by tumor cells and penetrates via diffu-
sion [125]. For such application, it is essential for the
SPIONs to be stable at neutral pH and physiological con-
ditions. The stability of the colloidal solution is dependent
on the dimension of the nanoparticle and their aggrega-
tion may be prevented by coating them with an appropri-
ate substance [126]. Larger particles (larger than 10 nm)
cannot penetrate the endothelium [127] under normal
conditions, but they can easily penetrate the tumor cells
and inflamed cells [128]. When the coated nanoparticles
enter the tumor cells, the coating is dissolved in the bio-
logical fluid and they are exposed to other cellular compo-
nents [111, 129].
However, if the concentration is increased, aggregation
of nanoparticles may occur leading to greater magnetic
interaction. It is also believed that agglomeration of
nanoparticles in the capillaries may block their passage
[130]. Since the biological pH and the isoelectric point
of SPION at pH 7 are the same [131, 132], they influ-
ence the colloidal stability of the SPIONs [133, 134].
It is essential that the drug-carrying spherical particles
must always be smaller than the RBC and the blood
capillaries where the drug is injected. The nanoparti-
cles after drug delivery are exposed to normal cells,
and therefore, it is essential that they should be non-
toxic to them.
Effect of Internalization of Nanoparticles
Calero and others [135] have studied the effect of intern-
alization of magnetic iron oxide nanoparticle on HeLa
cells in vitro. They also assessed the damage of normal
healthy cells and production of ROS. The internalization
was found to be dependent on the type of coating of
MNPs and their concentration. It was, however, noticed
that besides the increasing concentration of MNPs (0.05,
0.1, and 0.5 mg ml−1), the uptake of APS-coated iron
oxide nanoparticles by cells was higher than those
coated with AF or dimercaptosuccinic acid (DMSA)
[136]. The charge and surface of MNPs are important
since positively charged particle surface is attracted to-
wards negatively charged surface by default. Calero et al.
[135] have observed that APS-coated positively charged
nanoparticles are capable of penetrating easily into the
HeLa cell than the DMSA- and AD-coated MNPs. It can
be understood that positively charged MNPs are smaller
than the negatively charged species, and therefore, being
smaller in size, they can easily diffuse into the cells
which has also been demonstrated by Kenzaoui et al.
[137] in a separate experiment. The entrance of MNPs
follows endocytosis [138, 139]. Although substantial
number of MNPs accumulates in the cytoplasm and
does not reach the nucleus, genotoxic damage of iron
oxide MNPs due to the production of ROS occurs, irre-
spective of the cell type, coating, or their concentration.
Such nanosized magnetic materials may therefore be
used in medical diagnosis, especially in the identification
of cancer cells, MRI, and carrier for drug delivery.
Tumor Treatment
It was observed from a study of cancer cells exposed to
iron oxide nanoparticles that the cell death occurs by
necrosis rather than apoptosis. Interestingly, it was also
found that when normal human fibroblasts cells were
exposed to iron oxide nanoparticles, insignificant cell
death occurred. It demonstrates that these nanoparticles
can be safely used in the treatment of tumors without
damaging the healthy cells.
The ROS generation in this system was examined by
the probe when cancer cells A549 were treated with iron
oxide nanoparticles. The maximum ROS was generated
after 24 h at a rate of 100 μg/ml iron oxide nanoparticles
which subsequently induced autophagy [117].
Antibacterial Activity
Effect of iron nanoparticles on the deactivation of
Escherichia coli has been studied by Lee et al. [140]
under aerobic and anaerobic conditions. It was observed
that in the absence of oxygen, the inactivation of E. coli
was at maximum when exposed to 9 mg L−1 of iron
nanoparticles for 10 min.
In air-saturated solution containing as high as 90 mg L−1,
iron nanoparticles in E. coli solution exposed for
90 min had negligible inactivation of the bacteria.
This is particularly due to the presence of oxygen
which oxidizes the Fe0→Fe2+ and also the absence of
hydroxyl radical. The iron nanoparticles are oxidized
to FeO and Fe2O3 which form a film on the surface
of the nanoparticles preventing the lower layer from
further corrosion [141].
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Fe0 → FeO→ F2O3
However, when a chelating agent such as PO4
3− ion is
added in an air saturated system, the biocidal activity of
iron nanoparticle is reduced because Fe(III) forms an in-
soluble metal chelate with PO4
3− ion. On the contrary,
when oxalate ion, C2O4
2−, is added, the bactericidal activ-
ity is enhanced because it forms a soluble complex with
the iron ion. This is also evidenced and monitored from
a change in color from black to yellow.
Fe0 nanoparticles blackð Þ → Fe3þ yellowð Þ
Since Fe(II) is highly susceptible to oxidation by air, it
does not stay stable unless stabilized by an acid.
Superparamagnetic iron oxide nanoparticles are
frequently used as magnetic drug targeting, MRI, tis-
sue repair, etc. [142–146]. They are useful in drug
delivery. Since they can be guided by external electric
field to the desired target, they can stay there when
the magnetic field is cut off. Fe3O4 can be synthesized
by a variety of procedures. Their size and shape may
be controlled by monitoring the pH, temperature, and
concentration of the reacting components. Coating
with a suitable substance can prevent their agglomer-
ation. SPIONs (800 nm) were introduced to the fibro-
blast cells (Fig. 5) to examine the changes in their
morphology [147].
It was found that the toxicity increases with the shape
of SPIONs such as nanobeads, nanowires, and nano-
spheres. The deformation of the cell increases with the
concentration of SPIONs. The TEM images of fibroblast
cells exposed to SPION showed that smaller nanoparti-
cles penetrate into the cell (Fig. 6) while larger ones have
not been traced into them. The size is, therefore, of
Fig. 5 SEM results for a control L929 cells and the cells interacted with b nanobeads, c nanoworms, and d nanospheres. Panels e and f illustrate
the higher-magnification image of the surface of control L929 and the one interacted with nanospheres, respectively [156]
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prime importance in such cases, although the coating
also influences the size of the nanoparticles.
Although efforts are being made to produce SPION
coated with organic molecules for use in human system,
only dextran-coated SPIONs have so far been approved
by Food and Drug Administration (FDA) [135].
Mahmoudi et al. [49] have evaluated the toxicity of
bare SPION and those coated with –COOH and –NH2
against human cell lines HCM (heart), BE-2C (brain),
and 293T (kidney). The toxicity of bare SPION was
found to be higher than those coated with organic mole-
cules due to their greater affinity to absorb proteins, vi-
tamins, amino acids, and ions causing change in pH of
the medicine [148–150]. Since the human cell contains
proteins, vitamins, and amino acids, they have affinity to
bind with SPION whereas the SPIONs already coated
with these groups do not have vacant space for chelation
with them. The toxicity of the coated SPIONs is, there-
fore, less than those of uncoated ones. The low toxicity
of coated SPION is useful in the detection of cancer cells
because they do not damage the normal cells. One type
of SPION is toxic to certain types of cells while the other
types produce insignificant effect. For instance, Mah-
moudi and others [49] have reported that negative
SPIONs did not produce significant changes on the cyto-
skeleton of heart cells compared to high toxic effect on
the cytoskeleton of both kidney and brain cells.
Environmental Application of Magnetic Nanoparticles
Removal of Dyes
The iron nanoparticles produced from green tea leaf ex-
tract have been shown to contain iron oxide and oxo-
hydroxide [23]. They have been used as a Fenton-like
catalyst for the removal of organic dyes such as methy-
lene blue and methyl orange in aqueous medium. It has
been shown that they are highly effective in the removal
of cationic and anionic dyes over a wide range of con-
centrations (10–200 mg L−1). Also, the iron nanoparti-
cles synthesized from green tea leaf extract are more
effective than those produced from borohydride
reduction. Shahwan et al. [23] have reported that the
iron nanoparticles were washed with ethyl alcohol to re-
move NaCl from the sample. Since NaCl is an ionic salt,
it is soluble only in water and cannot be removed by
washing with ethyl alcohol. It was also noted that the
pH of methylene blue and that of methyl orange con-
taining iron nanoparticles was around 8.30. However,
the pH started declining immediately after the addition
of H2O2 until it became constant at 3.11 after about 6 h
when the dye was completely removed.
Pesticide Detection Sensor
Because of their application in agriculture, pesticides
have become one of the major environmental pollutants.
Iron oxide nanoparticle (Fe3O4) being chemically and
biologically neutral have been coated with catalysts, en-
zymes, or even antibodies to be used as biosensors
[151]. In a recently published paper, Chauhan et al. [152]
have modified Fe3O4 nanoparticle using poly(indole-5-
carboxylicacid) by preparing nanobiocomposite for its
use as a sensor for the determination of pesticides such
as malathion and chlorpyrifos in a wide range of concen-
trations (0.1–70 nm).
Iron nanoparticles in the elemental state have also
been used in the purification of ground water. It has
been tested against reductive dehalogenation of organo-
chlorine pesticides and insecticides [153–155] and sev-
eral other toxic substances such as chromium [156] and
arsenic [157]. Since agglomeration of iron nanoparticle
occurs, it was modified using surfactants. This not only
reduces the organochlorine pesticides but also prevents
corrosion. Mukherjee et al. [158] have shown that after
accepting H+, the hepatochlor pH increases which is
true but the term reduction used by them is incorrect as
the acceptance of proton, by definition, is oxidation.
Pesticides used in agriculture are sometime harmful to
other animals and plants. Their reduction to innocuous
chemicals by iron nanoparticle is a simple strategy to
make them useful. Polyhalogenated and nitroaromatic
compounds are generally reduced by metal
Fig. 6 TEM images of L929 cells for a control and b cells exposed to SPION with vesicle-containing SPION nanospheres [156]
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nanoparticles, metal sulfides, quinine, and vitamin B12.
Metal nanoparticles can also be used for the reduction
of nonhalogenated pesticides and azo dyes. The findings
made by Keum and Li [159] suggest remediation, but it
is too expensive to be used in the field. Also, it leaves
toxic residues in the environment.
Conclusions
Iron and iron oxide magnetic nanoparticles can be fabri-
cated by plant extracts or microbes such as fungi and
microalgae. They can be coated with water soluble poly-
mers for greater solubility. For instance, polyvinyl alcohol-
coated nanoparticles are prevented from aggregation;
therefore, they can easily diffuse through the semi-
permeable membrane in a living system. Their shape and
size may be controlled by maintaining the temperature,
pH, and concentration of the reacting components. Their
cytotoxicity varies with shape such as spherical, beads,
and rods. The hydrodynamic size and the paramagnetic/
diamagnetic nature of iron oxide nanoparticles make them
specific for specific application. For example, nanoparti-
cles with larger hydrodynamic size have lower cytotoxicity.
Superparamagnetic iron oxide nanoparticles have great
potential for use in instruments and medical devices, as
drug carrier, and in the treatment of many diseases. Mi-
crobes and plant extracts containing alkaloids, flavonoids,
saponins, ketones, aldehydes and phenols, or reducing
acids like citric acid and ascorbic acids can be used for
nanoparticle synthesis. Iron oxide nanoparticles can be
used as an inexpensive material for the removal of dyes
from textile industries and tanneries and in the treatment
of contamination in wastewater and purification of ground
water. Since the properties of iron oxide nanoparticles
solely depend on the number of unpaired electrons and
particle size in the presence and absence of magnetic field,
it can be altered by coating them with polymers and by
applying external magnetic field. These nanoparticles can
be selectively used for the separation of magnetic mate-
rials from a huge deposit of nonmagnetic substances.
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